These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative. Bahar M; Deng Y; Zhu X; He S; Pandharkar T; Drew ME; Navarro-Vázquez A; Anklin C; Gil RR; Doskotch RW; Werbovetz KA; Kinghorn AD Bioorg Med Chem Lett; 2011 May; 21(9):2606-10. PubMed ID: 21474310 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Structure and In Vitro Anti-Trypanosomal Activity of Non-Toxic Arylpyrrole-Based Chalcone Derivatives. Zulu AI; Oderinlo OO; Kruger C; Isaacs M; Hoppe HC; Smith VJ; Veale CGL; Khanye SD Molecules; 2020 Apr; 25(7):. PubMed ID: 32260364 [TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei. Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of new tetramethylpyrazine-based chalcone derivatives as potential anti-Alzheimer agents. Wang M; Qin HL; Leng J; Ameeduzzafar ; Amjad MW; Raja MAG; Hussain MA; Bukhari SNA Chem Biol Drug Des; 2018 Nov; 92(5):1859-1866. PubMed ID: 29923315 [TBL] [Abstract][Full Text] [Related]
9. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents. Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533 [TBL] [Abstract][Full Text] [Related]
10. Sterol 14alpha-demethylase (CYP51) as a therapeutic target for human trypanosomiasis and leishmaniasis. Lepesheva GI; Waterman MR Curr Top Med Chem; 2011; 11(16):2060-71. PubMed ID: 21619513 [TBL] [Abstract][Full Text] [Related]
11. Antileishmanial and antitrypanosomal activity of symmetrical dibenzyl-substituted α,β-unsaturated carbonyl-based compounds. Alkhaldi AA; de Koning HP; Bukhari SNA Drug Des Devel Ther; 2019; 13():1179-1185. PubMed ID: 31118564 [No Abstract] [Full Text] [Related]
12. Discovery of Novel Tetramethylpyrazine Containing Chalcone Derivatives as Anti-Inflammatory Agents. Bukhari SNA; Abdelgawad MA; Amjad MW; Munir MU; Sheikh FA Med Chem; 2023; 19(7):669-685. PubMed ID: 36635904 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-parasitic activity of a novel quinolinone-chalcone series. Roussaki M; Hall B; Lima SC; da Silva AC; Wilkinson S; Detsi A Bioorg Med Chem Lett; 2013 Dec; 23(23):6436-41. PubMed ID: 24119553 [TBL] [Abstract][Full Text] [Related]
14. Polyvinyl alcohol-based electrospun matrix as a delivery system for nanoemulsion containing chalcone against Leishmania (Leishmania) amazonensis. Coelho D; Veleirinho B; Mazzarino L; Alberti T; Buzanello E; Oliveira RE; Yunes RA; Moraes M; Steindel M; Maraschin M Colloids Surf B Biointerfaces; 2021 Feb; 198():111390. PubMed ID: 33208279 [TBL] [Abstract][Full Text] [Related]
15. Antitrypanosomal and Antileishmanial Activity of Chalcones and Flavanones from Zheoat AM; Alenezi S; Elmahallawy EK; Ungogo MA; Alghamdi AH; Watson DG; Igoli JO; Gray AI; de Koning HP; Ferro VA Pathogens; 2021 Feb; 10(2):. PubMed ID: 33562567 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of chalcone analogues with increased antileishmanial activity. Boeck P; Bandeira Falcão CA; Leal PC; Yunes RA; Filho VC; Torres-Santos EC; Rossi-Bergmann B Bioorg Med Chem; 2006 Mar; 14(5):1538-45. PubMed ID: 16386424 [TBL] [Abstract][Full Text] [Related]
17. Targeting the HSP60/10 chaperonin systems of Trypanosoma brucei as a strategy for treating African sleeping sickness. Abdeen S; Salim N; Mammadova N; Summers CM; Goldsmith-Pestana K; McMahon-Pratt D; Schultz PG; Horwich AL; Chapman E; Johnson SM Bioorg Med Chem Lett; 2016 Nov; 26(21):5247-5253. PubMed ID: 27720295 [TBL] [Abstract][Full Text] [Related]
18. The chemotherapeutic potential of chalcones against leishmaniases: a review. Tajuddeen N; Isah MB; Suleiman MA; van Heerden FR; Ibrahim MA Int J Antimicrob Agents; 2018 Mar; 51(3):311-318. PubMed ID: 28668673 [TBL] [Abstract][Full Text] [Related]
19. Molecular Targets for Chalcones in Antileishmanial Drug Discovery. de Santiago-Silva KM; da Silva Gomes GF; Perez CC; da Silva Lima CH; de Lima Ferreira Bispo M Mini Rev Med Chem; 2023; 23(14):1414-1434. PubMed ID: 36705240 [TBL] [Abstract][Full Text] [Related]
20. Study of the antibacterial and antifungal activities of synthetic benzyl bromides, ketones, and corresponding chalcone derivatives. Shakhatreh MA; Al-Smadi ML; Khabour OF; Shuaibu FA; Hussein EI; Alzoubi KH Drug Des Devel Ther; 2016; 10():3653-3660. PubMed ID: 27877017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]